These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32567678)
21. Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder. Diamandis M; Veljkovic DK; Derome F; Rivard GE; Hayward CP Blood Coagul Fibrinolysis; 2008 Jul; 19(5):463-4. PubMed ID: 18600101 [No Abstract] [Full Text] [Related]
22. [A novel CD36 mutation T538C (Trp180Arg) results in CD36 deficiency and establishment of a genotyping method for the novel mutation based on sequence-specific primer PCR]. Li L; He B; Zhou Y; Zhong Z; Li H; Lu F; Liu J; Shen W; Li H; Jiang L; Wu G Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):619-24. PubMed ID: 27577207 [TBL] [Abstract][Full Text] [Related]
23. A novel nucleotide substitution in the 5' untranslated region of ANKRD26 gene is associated with inherited thrombocytopenia: a report of two new families. Diep RT; Corey K; Arcasoy MO Ann Hematol; 2019 Jul; 98(7):1789-1791. PubMed ID: 30747248 [No Abstract] [Full Text] [Related]
24. A new Rhnull allele in francophone Quebecers. St-Louis M; Éthier C; Perreault J; Lavoie J Transfusion; 2015 Jun; 55(6 Pt 2):1580-1. PubMed ID: 25296744 [No Abstract] [Full Text] [Related]
25. [New insight into pathogenesis of idiopathic myelofibrosis--review]. Xu ZQ; Sun XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1330-4. PubMed ID: 18088495 [TBL] [Abstract][Full Text] [Related]
26. JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Barosi G; Bergamaschi G; Marchetti M; Vannucchi AM; Guglielmelli P; Antonioli E; Massa M; Rosti V; Campanelli R; Villani L; Viarengo G; Gattoni E; Gerli G; Specchia G; Tinelli C; Rambaldi A; Barbui T; Blood; 2007 Dec; 110(12):4030-6. PubMed ID: 17712047 [TBL] [Abstract][Full Text] [Related]
27. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459 [TBL] [Abstract][Full Text] [Related]
28. Chromosomal abnormalities in human neoplasia. Sandberg AA; Hossfeld DK Annu Rev Med; 1970; 21():379-408. PubMed ID: 4247449 [No Abstract] [Full Text] [Related]
29. No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis. Ditschkowski M; Elmaagacli AH; Trenschel R; Steckel NK; Koldehoff M; Beelen DW Biol Blood Marrow Transplant; 2006 Dec; 12(12):1350-1. PubMed ID: 17162218 [No Abstract] [Full Text] [Related]
30. Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production. Geddis AE; Kaushansky K Curr Opin Pediatr; 2004 Feb; 16(1):15-22. PubMed ID: 14758109 [TBL] [Abstract][Full Text] [Related]
31. Severe acquired platelet dysfunction because of primary myelofibrosis with full functional and morphological recovery after allogeneic hematopoietic cell transplantation. Linnik YA; Salvatore LT; Lowrey CH; Ornstein DL Blood Coagul Fibrinolysis; 2019 Dec; 30(8):419-422. PubMed ID: 31483321 [TBL] [Abstract][Full Text] [Related]
37. A string of 12 mutations in Intron 3 is a new clue associated with Type II CD36 deficiency. Lin FQ; Li XF; Li WW; Zhou ZR; Li JP Transfusion; 2019 Mar; 59(3):1159-1161. PubMed ID: 30840330 [No Abstract] [Full Text] [Related]
38. Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. Gresele P; Falcinelli E Thromb Haemost; 2001 Sep; 86(3):728-30. PubMed ID: 11583300 [No Abstract] [Full Text] [Related]
39. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation. Hussein K; Bock O; Seegers A; Flasshove M; Henneke F; Buesche G; Kreipe HH Blood; 2007 May; 109(9):4106-7. PubMed ID: 17449802 [No Abstract] [Full Text] [Related]
40. High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension. Popat U; Frost A; Liu E; Guan Y; Durette A; Reddy V; Prchal JT Blood; 2006 May; 107(9):3486-8. PubMed ID: 16418333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]